Results 201 to 210 of about 928,903 (364)

PCSK‐9 Inhibitors Can Significantly Improve the Coronary Slow Flow Caused by Elevated Lipoprotein (a) in ST‐Elevation Myocardial Infarction Patients With Chronic Kidney Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary slow flow and no reflow significantly predict poor prognosis in acute myocardial infarction (AMI) patients, especially those with chronic kidney disease (CKD). Early identification of factors contributing to these conditions can mitigate ischemic events and improve outcomes.
Hao Xu, Ziqing Wang, Dan Chen, Haojie Zhang, Junhua Ge, Jian Li   +5 more
wiley   +1 more source

Heart valve disease: investigation by cardiovascular magnetic resonance [PDF]

, 2012
Saul Myerson
openalex   +1 more source

Novel Techniques for Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy With Complex Anatomy: A Case Series

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Alcohol septal ablation (ASA) is an established treatment for hypertrophic obstructive cardiomyopathy (HOCM). However, conventional techniques may be challenging in cases with complex septal branch anatomy, including hairpin curves, extremely small branches, and acute angle bifurcations.
Junya Matsuda, Yukichi Tokita, Hitoshi Takano, Kuniya Asai   +3 more
wiley   +1 more source

Recent advancements in polymeric heart valves: From basic research to clinical trials

Materials Today Bio
Valvular heart diseases (VHDs) have become one of the most prevalent heart diseases worldwide, and prosthetic valve replacement is one of the effective treatments. With the fast development of minimal invasive technology, transcatheter valves replacement
Yuanchi Wang, Yulong Fu, Qingyu Wang, Deling Kong, Zhihong Wang, Jing Liu   +5 more
doaj  

Upregulation of SR-PSOX/CXCL16 and Recruitment of CD8 ⁺ T Cells in Cardiac Valves During Inflammatory Valvular Heart Disease

, 2003
Ryoko Yamauchi, Makoto Tanaka, Noriaki Kume, Manabu Minami, Takahiro Kawamoto, Kiyonori Togi, Takeshi Shimaoka, Shu Takahashi, Junko Yamaguchi, Takeshi Nishina, Masanori Kitaichi, Masashi Komeda, Mitsuyoshi Hirokawa, Shin Yonehara, Toru Kita   +14 more
openalex   +1 more source

Heart Valve Disease: Challenges and New Opportunities [PDF]

Frontiers in Cardiovascular Medicine, 2020
Francesca Bartoli-Leonard, Elena Aikawa, Elena Aikawa, Elena Aikawa   +3 more
openaire   +4 more sources

Restoration of a Stuck Leaflet

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Severe aortic regurgitation (AR) for a leaflet malfunction after transcatheter aortic valve implantation (TAVI) is a dreadful complication that can lead even to cardiogenic shock. New valve's design has reduced the rate of paravalvular regurgitation, however central regurgitation is still a challenging complication.
Elisa Tomarelli, Gianluca Di Pietro, Gennaro Sardella, Massimo Mancone   +3 more
wiley   +1 more source

Hybrid Transcatheter Pulmonary Valve Replacement With SAPIEN S3 Following Right Ventricular Outflow Tract Reduction Using Tricuspid Annuloplasty Rings

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT We describe a novel variation of hybrid TPVR using a tricuspid annuloplasty ring which can be considered for patients with very large RVOT, short pulmonary artery, and limited vascular access and to avoid the risk of cardiopulmonary bypass. The utilization of Carpentier‐Edwards Physio Tricuspid annuloplasty ring can reduce the size of the RVOT
Mann Chandavimol, Piya Samankatiwat, Alisa Limsuwan, Tawai Ngernsritrakul, Jamil Aboulhosn   +4 more
wiley   +1 more source

Cardiac Troponin‐I Concentration, Myocardial Arteriosclerosis, and Fibrosis in Dogs with Congestive Heart Failure because of Myxomatous Mitral Valve Disease [PDF]

, 2013
T. Falk, Ingrid Ljungvall, N.E. Zois, Katja Höglund, Lisbeth H. Olsen, Henrik D. Pedersen, Jens Häggström   +6 more
openalex   +1 more source

Complications Leading to Death in Patients Supported by the Impella 5.5: Analysis From the FDA MAUDE Database

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The Impella 5.5 is increasingly being used in patients with cardiogenic shock, but experience with the device remains limited, and severe complications, including death, have been reported. This study aims to investigate causes of Impella 5.5‐related deaths.
Omar Khalil, Hussein Krayem, Aditya Kesari, Arun U. Mahtani, Matthew G. Kaye, Charlotte Roberts, Inna Tchoukina, Melissa C. Smallfield, Josue Chery, Zubair A. Hashmi, Michael C. Kontos, Keyur B. Shah, Pengyang Li   +12 more
wiley   +1 more source